160 related articles for article (PubMed ID: 28467996)
1. Increased Risk of Bullous Pemphigoid after First-Ever Stroke: A Population-Based Study.
Shen AL; Lin HL; Lin HC; Tseng YF; Hsu CY; Chou CY
Neurodegener Dis; 2017; 17(4-5):166-170. PubMed ID: 28467996
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study.
Yang YW; Chen YH; Xirasagar S; Lin HC
Stroke; 2011 Feb; 42(2):319-23. PubMed ID: 21164122
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis is associated with increased risk of bullous pemphigoid: A nationwide population-based cohort study in Taiwan.
Ho YH; Hu HY; Chang YT; Li CP; Wu CY
J Dermatol; 2019 Jul; 46(7):604-609. PubMed ID: 31062428
[TBL] [Abstract][Full Text] [Related]
4. Cancer is not a risk factor for bullous pemphigoid: 10-year population-based cohort study.
Chen CT; Hu HY; Chang YT; Li CP; Wu CY
Br J Dermatol; 2019 Mar; 180(3):553-558. PubMed ID: 30216411
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.
Liu YD; Wang YH; Ye YC; Zhao WL; Li L
Arch Dermatol Res; 2017 Jul; 309(5):335-347. PubMed ID: 28317060
[TBL] [Abstract][Full Text] [Related]
6. The association of dipeptidyl peptidase IV inhibitors and other risk factors with bullous pemphigoid in patients with type 2 diabetes mellitus: A retrospective cohort study.
Guo JY; Chen HH; Yang YC; Wu PY; Chang MP; Chen CC
J Diabetes Complications; 2020 Mar; 34(3):107515. PubMed ID: 31932172
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.
Chen YJ; Wu CY; Lin MW; Chen TJ; Liao KK; Chen YC; Hwang CY; Chu SY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Br J Dermatol; 2011 Sep; 165(3):593-9. PubMed ID: 21517800
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.
Kibsgaard L; Rasmussen M; Lamberg A; Deleuran M; Olesen AB; Vestergaard C
Br J Dermatol; 2017 Jun; 176(6):1486-1491. PubMed ID: 28235244
[TBL] [Abstract][Full Text] [Related]
10. Neurological Cancer is a Risk Factor for Bullous Pemphigoid: 11-Year Population-Based Cohort Study.
Wu CY; Hu HY; Chou YJ; Li CP; Chang YT
Am J Clin Dermatol; 2020 Aug; 21(4):591-597. PubMed ID: 31820332
[TBL] [Abstract][Full Text] [Related]
11. Incidence of bullous pemphigoid in Sweden 2005-2012: a nationwide population-based cohort study of 3761 patients.
Thorslund K; Seifert O; Nilzén K; Grönhagen C
Arch Dermatol Res; 2017 Nov; 309(9):721-727. PubMed ID: 28875235
[TBL] [Abstract][Full Text] [Related]
12. The association between bullous pemphigoid and neurological disorders: a systematic review.
Milani-Nejad N; Zhang M; Kaffenberger J
Eur J Dermatol; 2017 Oct; 27(5):472-481. PubMed ID: 28681724
[TBL] [Abstract][Full Text] [Related]
13. A population-based study of the association between bullous pemphigoid and neurologic disorders.
Brick KE; Weaver CH; Savica R; Lohse CM; Pittelkow MR; Boeve BF; Gibson LE; Camilleri MJ; Wieland CN
J Am Acad Dermatol; 2014 Dec; 71(6):1191-7. PubMed ID: 25174542
[TBL] [Abstract][Full Text] [Related]
14. Bullous pemphigoid and neurological disease: statistics from a dermatology service.
Tarazona MJ; Mota AN; Gripp AC; Unterstell N; Bressan AL
An Bras Dermatol; 2015; 90(2):280-2. PubMed ID: 25831008
[TBL] [Abstract][Full Text] [Related]
15. Mortality and risk factors among Israeli bullous pemphigoid patients.
Rozenblat M; Halaj A; Rozenblat T; Fisher S; Sah M; Dodiuk-Gad RP; Ziv M
Arch Dermatol Res; 2019 Jan; 311(1):19-27. PubMed ID: 30382340
[TBL] [Abstract][Full Text] [Related]
16. Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid?
Foureur N; Descamps V; Lebrun-Vignes B; Picard-Dahan C; Grossin M; Belaich S; Crickx B
Eur J Dermatol; 2001; 11(3):230-3. PubMed ID: 11358730
[TBL] [Abstract][Full Text] [Related]
17. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
18. Association of Immunosuppressants with Mortality of Patients with Bullous Pemphigoid: A Nationwide Population-Based Cohort Study.
Wu CY; Wu CY; Li CP; Lin YH; Chang YT
Dermatology; 2022; 238(2):378-385. PubMed ID: 34139703
[TBL] [Abstract][Full Text] [Related]
19. Risk of bullous pemphigoid and pemphigus in patients on chronic dialysis: A nationwide population-based cohort study.
Tang CH; Sue YM; Chang CL; Wang CC
J Dermatol; 2023 Dec; 50(12):1568-1575. PubMed ID: 37665203
[TBL] [Abstract][Full Text] [Related]
20. Association between chronic kidney disease and risk of bullous pemphigoid: a nationwide population-based cohort study.
Yu WT; Ma SH; Wu CY; Chen YL; Chang YT; Wu CY
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1480-1487. PubMed ID: 37830438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
